Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The International Papillomavirus Society proclaimed March 4th as “International HPV Awareness Day”.
A look back at some of the most important science and treatment news Cancer Health covered this year.
Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
Data from early clinical trials suggest new precision cancer treatments are on the horizon.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.
The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.
Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.
In a new initiative, the Grammy-winning artist advises Black women to protect their cervical health with annual Pap and HPV tests.
The National Comprehensive Cancer Network publishes a new guide that includes updated patient guidelines for colon and rectal cancers.
The early cancer is detected, the easier it is to treat.
However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.
Study participants who received Libtayo had a 31% lower risk of death than those treated with chemotherapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.